PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
23-May-2023 Flexicon’s integrated solution for Müggenburg Pharma's filling line increases capacity for high-value product Flexicon
23-May-2023 Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform Tiziana Life Sciences
23-May-2023 AnaMar Announces Positive Phase I Data for its Phase II Ready Compound AM1476 for Treating Fibrosis AnaMar
23-May-2023 FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients XBiotech
23-May-2023 Orgenesis Academy graduates first class of cell and gene therapy experts from theraCell Laboratories-backed master’s program Orgenesis
23-May-2023 Alfa Chemistry’s Laboratory Increases Capability for Water Analysis, Resin Analysis, and Chromatography Analysis Alfa Chemistry
22-May-2023 Integra Therapeutics CEO Avencia Sánchez-Mejías to speak at Global Synthetic Biology Conference Integra Therapeutics
19-May-2023 Orgenesis to participate in Benchmark’s third Annual Healthcare House Call Virtual 1x1 Investor Conference on May 23, 2023 Orgenesis
19-May-2023 CD Genomics Expands Services with Pre-made Library Sequencing for High-Throughput Analysis CD Genomics
19-May-2023 CD Genomics Harnesses Single-cell DNA Methylation Sequencing Service to Drive Scientific Breakthroughs CD Genomics
19-May-2023 CD Genomics Unveils Cutting-Edge Long-Read Metagenomic Sequencing Service CD Genomics
19-May-2023 CD Formulation: Prescription Screening Process Analysis Provides New Possibilities for Pharmaceutical Industry CD Formulation
18-May-2023 CD Formulation Exhibits Proficiency in Contact Angle Determination of Pharmaceutical Excipients CD Formulation
18-May-2023 New Offerings Released at Alfa Chemistry: Isoquinoline Alkaloids, Pyridine Alkaloids, and Phenylethylamine Alkaloids Alfa Chemistry
16-May-2023 Peer-reviewed translational research paves the way for first-in-class autotaxin inhibitor IOA-289 in cancer iOnctura
16-May-2023 Bloomsbury Genetic Therapies Announces Clinical Trial Application Accepted by U.K. Regulatory Agency to Initiate Phase 1/2 Gene Therapy Trial of BGT-OTCD for the Treatment of Ornithine Transcarbamylase Deficiency (OTCD) Bloomsbury Genetic Therapies
16-May-2023 TILT Biotherapeutics Announces First Patient Dosed in Phase I Solid Tumors Trial Assessing Oncolytic Adenovirus TILT-123 in Combination with Checkpoint Inhibitor TILT Biotherapeutics
16-May-2023 Emerging Trends in Single Use Bioprocessing: Advancements and Market Opportunities Markets and Markets
16-May-2023 Alfa Chemistry: Lithium-Ion Battery Testing Contributes to Enhanced Battery Performance Alfa Chemistry
16-May-2023 New Partnership Established: Alfa Chemistry Adds 200,000+ Chemicals to Spaya Database Alfa Chemistry